Since the previous update on 3 May 2023, and as of 7 June 2023, no MERS-CoV cases have been reported by health authorities worldwide or by the World Health Organisation (WHO).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 June 2023 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), COVID-19, Mpox, Marburg virus disease and West Nile virus.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 May - 3 June 2023 and includes updates on COVID-19, West Nile virus, Legionnaires' disease, avian influenza, Marburg virus disease, cholera, and fungal meningitis.
EU/EEA countries are reporting an increased number of Escherichia coli (E. coli) isolates carrying the blaNDM-5 gene that makes them resistant to carbapenems, antibiotics.
Analysis of whole genome sequencing and epidemiological data of 874 E. coli isolates from the national collections of 13 countries confirmed the increase of E. coli isolates carrying blaNDM-5 which was previously detected in the CCRE survey.
Between 2018 and 2020, nearly 20 000 surgical site infections (SSIs) were reported from a total of over 1.2 million surgical procedures in 13 EU/EEA countries participating in ECDC-coordinated SSI surveillance. Over 2 500 hospitals are part of this surveillance network.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 April - 6 May 2023 and includes updates on COVID-19, influenza, echovirus, Marburg virus, mpox, MERS, and the seizure of a reference laboratory in Sudan.
Since the previous update on 11 April 2023, and as of 3 May 2023, no new MERS-CoV cases and no
related deaths have been reported by health authorities worldwide or by the World Health Organization (WHO).
Since the previous update on 11 April 2023, and as of 3 May 2023, no new MERS-CoV cases and no
related deaths have been reported by health authorities worldwide or by the World Health Organization (WHO).